Our tumor marker antigens and antibodies target key cancer biomarkers with high specificity and purity. These reagents enable precise detection in immunoassays, supporting early diagnosis, therapy monitoring, and prognosis assessment. Stringent quality control ensures consistent lot-to-lot performance and reliable results in clinical and research oncology applications.